Direxion Daily S&P Biotech Bull 3X ETF
LABU
28 hedge funds and large institutions have $35.5M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2021 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 4 closing their positions.
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
40% more capital invested
Capital invested by funds: $25.3M → $35.5M (+$10.2M)
40% more funds holding
Funds holding: 20 → 28 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.11% less ownership
Funds ownership: 0.38% → 0.28% (-0.11%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
17% less call options, than puts
Call options by funds: $86.7M | Put options by funds: $104M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$13.2M |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$4.85M |
| 3 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$4.1M |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$2.84M |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$6.81M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.32M |
| 3 |
HF
HRT Financial
New York
|
-$1.31M |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$843K |
| 5 |
MIC
Means Investment Company
Bangor,
Maine
|
-$301K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | – | – | – |
|
|
IF
27
Ironwood Financial
Tucson,
Arizona
| $7K | +$9.37K | +4 | New |
|
|
AWM
28
Activest Wealth Management
Aventure,
Florida
| $3K | +$4.68K | +2 | New |
|
|
MIC
29
Means Investment Company
Bangor,
Maine
| – | -$301K | -95 | Closed |
|
|
SFP
30
Sterling Financial Planning
Sparta,
New Jersey
| – | -$8K | -4 | Closed |
|
|
TFA
31
Toth Financial Advisory
Leesburg,
Virginia
| – | -$5K | -3 | Closed |
|
|
ASN
32
Advisory Services Network
Atlanta,
Georgia
| – | -$1K | -1 | Closed |
|
LABU Hedge Fund Activity: Q1 2021 in Review
28 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q1 2021, worth a combined $35.5M — up 40% from $25.3M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new LABU positions and 4 closed out — a net gain of 8 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $13.2M. The largest seller was Citadel Advisors, cutting an estimated $6.81M.
- 28 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q1 2021, up from 20 in Q4 2020.
- Funds reported $35.5M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q1 2021, up 40% quarter-over-quarter.
- 12 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q1 2021 and 4 closed out, a net change of +8 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q1 2021 was Jane Street, an estimated $13.2M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q1 2021 was Citadel Advisors, an estimated $6.81M sold.
Based on aggregated 13F filings for Q1 2021.